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Abstract 
Phytochemicals have been found to be promising alternatives to conventional antibiotic 
therapies for the control of bacterial infections, as they may entail less selective pressure and 
hence reduce the development of resistance. This study involved examining the inhibition of 
biofilm formation and of quorum sensing (QS), and the cytotoxicity on mammalian cells of 
two flavonoids, quercetin and baicalein, in free form and associated into chitosan-based 
nanocapsules. This was done by use of a transformed E. coli Top 10 biosensor strain, while the 
cytotoxicity was evaluated on MDCK-C7 cells. In free form, application both phytochemicals 
exhibited slight inhibitory activity on the QS response and biofilm formation, a scenario that 
was improved positively upon encapsulation with chitosan (Mw ~115 kg/mol and DA ~42%). 
The association efficiency of 99% (quercetin) and 87% (baicalein) was obtained, and both had 
an average diameter of 190 ± 4nm & 187 ± 2nm and zeta potential (ȗRIP9	
48.4 ± 3.46mV respectively. Both types of systems were stable against aggregation in M9 and 
MEM media. The in vitro release kinetics data of both baicalein and quercetin seemed to be 
similar with only ~20 % over the first 5 h, and only ~10% was released during the first 4h 
respectively with subsequent sudden release increase up to ~40 % afterwards.  The free 
phytochemicals seemed to be cytotoxic to MDCK-C7 cells at higher doses, however, upon 
nanoencapsulation, a cytoprotective effect was evidenced. We have gained proof-of-principle 
of the advantages of encapsulation of two bioactive flavonoids.  
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1. Introduction 
Bacterial quorum sensing (QS) is an area that currently has drawn increasing interest especially 
in bacterial pathogenicity as its responsibility to their phenotypic traits. QS is a cell-to-cell 
communication process that enables bacteria to assume a collective synchronous behaviour 
under the influence of chemical signalling molecules called autoinducers (AIs) which mediates 
interspecies or intraspecies behaviours[1]. As the cell density increases, AIs accumulate in the 
environment and they are sensed by protein receptors, which in turn act as transcriptional 
activators for the expression of specific genes; the products of these genes direct activities that 
are beneficial when performed by bacterial communities acting in synchrony [1]. Homoserine 
lactones (HSLs) produced by Gram-negative bacteria are the best studied AIs and possibly the 
most common group of bacterial QS AIs while Gram-positive bacteria use small peptides called 
AI2 [2, 3]. Frequently, pairs of genes encoding the HSL synthase and the HSL-sensing 
transcriptional regulator are found close to each other in bacterial genomes [4]. This 
phenomenon was first discovered in the marine bacterium Vibrio fischeri [5] and the term 
quorum sensing was later coined by Fuqua et al., [6] referring to the acylated homoserine 
lactone (AHL)-mediated luxR/luxI regulated system. 
Biofilm formation is one of the virulence traits associated to QS [7]. Bacteria in biofilms are 
not easily reached neither by antibiotic agents nor by the host immune system as they act as 
diffusion barriers hence they continue multiplying inside the extracellular matrix up to a point 
at which they disperse to start forming new biofilm communities [8]. Microbial biofilms readily 
form on indwelling medical devices and cause serious diseases that are hard to control since 
effective therapy is lacking. According with CDC and NIH, between 65%±80% of infections 
could be caused by biofilms, demonstrating the need to develop improved treatment options 
[9].  
Therefore, targeting and blocking QS circuits in bacteria may represent a strategy to disarm 
their virulence and hence, making them more susceptible to elimination by the host immune 
system or low doses of antibiotics [10]. Anti-virulent agents possessing QS inhibitory activity 
might not pose selective pressure on bacterial pathogens and hence, may contribute to reduce 
the rapid emergence of so-FDOOHG³VXSHUEXJV´EDFWHULDUHVLVWDQWWRVHYHUDODQWLELRWLFV[11, 12].  
Disruption of QS-regulated processes has been accepted to reduce accumulation of virulence 
factors at the infection site, and dismantles the collective virulent power of pathogens. These 
strategies are collectively called quorum quenching (QQ) [13].  
Plant phytochemicals may be possessing anti-quorum sensing activities based on the various 
studies. Among them include, but are not limited to, zingerone [12], curcumin [14], cinnamon 
oil [15], pure trans-cinnamaldehyde [16, 17], proanthocyanidins [18], and flavonoids like 
quercetin [19]. On the other hand it is now known that the activity of anti-virulent agents or 
antimicrobials may improve upon encapsulating them in biopolymer-based materials [20, 21]. 
This may be attributed to the overall increase in their bioavailability, lower dosage release for 
longer periods; to the overcoming physiological barriers resistances e.t.c as compared to free 
agents [20-22].  
Different types of nanocarrier formulations have extensively been used for drug delivery [23, 
24]. Despite this, minimal information is available for their use in delivering QS inhibitory 
  
agents. However, biologically-derived materials such as polysaccharides and proteins can be 
used as components of nanoformulations as they are fully biodegradable, biocompatible and 
non-immunogenic. Hence, they are attractive for the development of innovative drug delivery 
vehicles [25]. Among the most interesting biopolymers in this area, is chitosan that has gained 
enormous traction. Chitosan are a family of amino linear heteropolysaccharides comprised by 
ȕ -4) 2-acetamido-2-deoxy-ȕ-D-glucopyranose (N-acetyl glucosamine) and 2-amino-2-
deoxy-ȕ-D-glucopyranose (D-glucosamine) units, randomly or distributed as blocks 
throughout the biopolymer [26]. Chitosan and its chemical derivatives are particularly 
attractive as a building blocks for drug delivery nanoformulations in light of its 
biocompatibility, biodegradability, bio± and mucoadhesivity, and hydrophilic character that 
facilitate the administration of poorly absorbable drugs across various epithelial barriers [27- 
31]. It can also be easily be manipulated chemically and hence forming a good vehicle for 
delivering both hydrophobic and hydrophilic drugs/agents to target sites [26]. 
Quercetin and baicalein (Supplementary data - S1) are both bioflavonoids that are lipophilic. 
They are the most common polyphenolic compounds in nature and are found ubiquitously in 
plants, including food products like onions, many fruits, or in herbs [32-35]. Previous studies 
have shown that quercetin and baicalein can act as competitive inhibitors for the signalling 
compound towards LasR/Rh1R and orphan regulator QscR receptors pathway commonly 
found with P. aeruginosa and can serve as novel QS-based antivirulence agents to manage 
such groups of pathogens [19, 36 - 38]. In these studies, it was deduced that both flavonoids 
have both antivirulence and antibiofilm formation activity against P. aeruginosa PA01. 
However, only few of the available studies have reported on the role of plant extracts and 
phytochemicals as QS inhibitors, deal with the potential mechanisms of action [39] and even 
their activity upon nanoencapsulation.  
In this study, we report the AQS & antibiofilm activities of free and chitosan nanoencapsulated 
quercetin and baicalein against a bioengineered E. coli Top 10 biosensor that has a Lux R 
receptor pathway. Also their viability towards MDCK±C7 mammalian cell line was 
determined. 
2. Materials and Methods 
2.1:  Materials 
The parent chitosan (Mw 288 kDa and DA-16%) was provided by Mahtani Chitosan Pvt. Ltd., 
India (Sample code 132; batch no. SCCF 20140609). The chitosan used for this study was 
derived from this parent sample as described in previous studies [40, 41]; the Mw was 115 
kg/mol as determined by HPSEC-MALLS and the DA of 42 % as measured by 1H-NMR 
spectroscopy according with the method by Lavertu et al. [42]. Lecithin was a kind gift from 
Cargill (Epikuron 145 V, Cargill Deutschland GmbH & Co. KG, Hamburg, Germany); Miglyol 
812 N was from Sasol GmbH (Witten, Germany). 3OC6HSL and all other chemicals were of 
analytical grade and unless otherwise stated were from Sigma (Sigma-Aldrich, Hamburg, 
Germany). 
  
2.2: Baicalein and quercetin nanocapsules formulation 
CS-based nanocapsules of both baicalein (Mw- 270.24) and quercetin (Mw- 302.24) were 
prepared according with the protocol originally developed in our laboratory with some slight 
modifications [25, 43]. Briefly, due to the hydrophobic nature of the two phytochemicals 1mg 
RIHDFKZDVGLVVROYHGLQP/RIDEVROXWHHWKDQRO7KHQȝ/RIWKHHDFKRIWKHSK\WRFKHPLFDO
ZDVWDNHQȝ/RIOHFLWKLQ1PJP/RIOHFLWKLQLQHWKDQRODQGȝ/RI0LJO\RO® 
were added to a beaker with 4.75 mL of absolute ethanol. Immediately afterwards, this organic 
phase was poured into of 10 mL of CS solution (0.5 mg/mL) which turned milky. Ethanol and 
a portion of the volume of water were evaporated in a rotavapor at 40 °C for ~8-15 min to a 
final volume corresponding with one third of the original one. The blank NCs were also made 
according with the same protocol but no phytochemicals were added in the organic phase. All 
preparations were made in triplicates.  
2.3: Physicochemical properties of the nanocapsules  
The size distribution of the nanoformulations was determined by dynamic light scattering with 
non-invasive back scattering (DLS-NIBS) with a measurement angle of 173°. The zeta 
potential was measured by mixed laser Doppler velocimetry and phase analysis light scattering 
(M3±PALS). A Malvern Zetasizer NanoZS (Malvern Instruments Ltd., Worcestershire, UK) 
ILWWHGZLWKDUHGODVHUOLJKWȜ QPZDVXVHGIRUERWKPHWKRGV7KHVDPSOHVZHUHGLOXWHG
1:100 in acidified water before measurement. 
2.4: Encapsulation/association efficiency 
It was determined as per the method used by Kaiser et al. [25]. Briefly, aliquots of 500 µL of 
the flavonoid-loaded nanoformulations were pipetted into Vivaspin® 500 ultrafiltration spin 
columns and then were centrifuged by centrifuge (Mikro 220 R, Hettich GmbH & Co. KG, 
Tuttlingen, Germany) at 16,000 rpm for 1 h at 15 °C. Free baicalein and quercetin content of 
the subnatant were determined by UV spectroscopy at O = 324 and 374 nm, respectively using 
the corresponding calibration curves (Supplementary data-S2). The association efficiency was 
calculated as the difference between the total amount of the flavonoid incorporated in the 
formulation and the amount present in the subnatant. The association of quercetin was also 
determined by resuspending the creamy layer with distilled water up to 1 mL and then 25 µL 
were taken and then mixed with 475 µL of absolute ethanol and the concentration was 
determined as described above, as a confirmation of the previous method results.  
2.5: Stability test with M9 and MEM medium 
The colloidal stability of both baicalein and quercetin NCs was investigated by using minimal 
essential medium Eagle (MEM M4655, Sigma-Aldrich) (pH 7.45) cell culture medium without 
supplements and M9 bacterial growth medium. Briefly 50 µLs of either baicalein or quercetin 
NCs were added to 950 µLs in a sterile cuvette of either MEM or M9 medium and incubated 
at right conditions (M9 at 37 °C for 48h and for MEM at 37 °C, 5% CO2 environment & 24h). 
The stability was evaluated in terms of the evolution of the particle size distribution and size 
(nm) of the NCs over time during incubation at 37 °C for up to ~24 h for MEM or ~48 h for 
M9 medium by use of the Malvern Zetasizer NanoZS as described above.  
  
2.6: Release assay 
The release assay of the developed NCs was investigated in the M9 bacterial growth medium.  
Briefly an aliquot of 800 ȝ/RIHLWKHUEDLFDOHLQRUTXHUFHWLQ1&VZDVWUDQVIHUUHGWRDGLDO\VLV
tube (Pure-a-lyzer Maxi 0.1±3.0 ml, Mw cut-off = 6 kDa, Sigma-Aldrich GmbH, Steinheim, 
Germany) and placed in a sterile glass beaker with 79.2 mL of M9 medium previously 
equilibrated at 37 °C in an incubator. This set-XSHQVXUHGWKDW³VLQN´conditions were achieved. 
Every hour an aliquot of 500 ȝOZDVdrawn from the dialysate and the same amount of fresh 
M9 medium replenished. Baicalein or quercetin content of the aliquots was determined by UV 
spectrophotometry as described above. The release experiment lasted 6 h. 
2.7: Bioassays  
2.7.1: Bacterial strain 
E. coli Top10 was transformed with the plasmid pSB1A3-BBa_T9002, carrying the 
BBa_T9002 genetic device (Registry of Standard Biological Parts: 
http://parts.igem.org/Part:BBa_T9002), kindly donated by Prof. Anderson Lab (UC Berkeley, 
USA). The sequence BBa_T9002 was introduced by chemical transformation (Invitrogen, Life 
Technologies Co., UK) and stored as a 30 % glycerol stock at ±80 ºC. The transformed strain 
is a biosensor that can respond to the N-(3-oxohexanoyl)-L-homoserine lactone (3OC6HSL) 
and is the same strain used in accompanying studies [44]. The sequence BBa_T9002, 
comprised the transcription factor (LuxR), under the control of the lux pR promoter from Vibrio 
fischeri, which is constitutively expressed with GFP production only in the presence of the 
exogenous cell-cell signaling molecule 3OC6HSL.  
2.7.2: Growth media and conditions 
Bacterial strains were cultivated using on Luria-Bertani (LB) and M9 minimal medium 
(Becton, Dickinson and company, Germany). We inoculated 10 mL of LB broth supplemented 
with 10µL (200 µg/mL) ampicillin (AppliChem GmbH, Germany) with a single colony from 
a freshly streaked plate of E. coli Top10 containing BBa_T9002 and incubated the culture for 
18 h at 37ºC, shaking at 100 r.p.m. Each culture was then diluted 1:1000 into 20 mL M9 
minimal medium supplemented with 0.2% casamino acids and 1 mM thiamine hydrochloride 
plus 20µL (200 µg/mL) ampicillin. The culture was maintained under the same conditions until 
the OD600 reached 0.15 (~5 h). Then 500 µL of the overnight culture were mixed with 500µl 
30% sterile glycerol together in the white plastic vials and stored at -8ࡈ C for future use. Before 
the biosensor assay, the bacteria cultivation was prepared by cultivating 40µL of thawed 
bacteria from the white plastic vial kept at -8ࡈ C unto 20 mL M9 medium plus 20µl of 
ampicillin (200 g/mL). This is incubated at 37ࡈ C, 100 r.p.m until the OD600 reached 0.04~ 0.07 
(~4 h). 
2.7.3: E. coli Top10 biosensor QS assay 
The N-ȕ-ketocaproyl)-L-homoserine lactone (Sigma- Aldrich) (3OC6HSL) was dissolved in 
acetonitrile to a stock concentration of 100 mM and stored at ±20ºC. Prior to the biosensor 
assay, a 5 µL aliquot of this stock solution was diluted with sterile milli-Q water to a final 
concentration of 10 nM. Then 10 µL of 10 nM 3OC6HSL aqueous solution was placed with 10 
  
µL of the treatment samples in the wells of a flat-bottomed 96-well plate (Greiner Bio-One, 
cat. # M3061) and each well was then filled with 180 µL aliquots of the bacterial culture of 
OD600 0.04~ 0.07 to test for QS inhibition activity. Several controls were also set up. Blank 1 
contained 180 µL of M9 medium and 20 µL of milli-Q water to measure the absorbance 
background. Blank 2 wells contained 180 µL of bacterial culture and 20 µL of milli-Q water 
to measure the absorbance background corrected for the cells. Finally, positive control wells 
contained 10 µL of water plus 10 µL 3OC6HSL solution and 180 µL of the bacterial culture to 
measure the fluorescence background. In order to remove the effect of samples themselves with 
OD600 and fluorescence, 10 µL 3OC6HSL solution was added with 10 µL of the treatment 
samples in the wells and each well was then filled with 180 µL M9 medium to test the samples 
control in biosensor assay. 
The plates were incubated in a Safire Tecan-F129013 Microplate Reader (Tecan, Crailsheim, 
Germany) at 37 ºC and fluorescence measurements were taken automatically using a repeating 
SURFHGXUH Ȝex  QP DQG Ȝem=510nm, 40 µs, 10 flashes, gain 100, top fluorescence), 
absorbance measurements (OD600Ȝ QPDEVRUEDQFHILOWHUIODVKHVDQGVKDNLQJV
orbital shaking, high speed). The interval between measurements was 6 min. For each 
experiment, the fluorescence intensity (FI) and OD600 data were corrected by subtracting the 
values of absorbance and fluorescence backgrounds and expressed as the average for each 
treatment. All measurements were taken in triplicate.2.8: Antibiofilm assay 
Microtiter plate assay as used before [45] with some modifications was performed to quantify 
the effect of both free and nanoencapsulated baicalein and quercetin on the biofilm formation 
of E. coli Top 10 biosensor strain. The test bacteria stored at -80ࡈ C in vials was first thawed 
and inoculated on LB agar and incubated at right conditions at 37ࡈ C overnight. Then a colony 
was identified and was picked and inoculated unto 10mLs of LB broth and was incubated 100 
r.p.m, 37ࡈ C overnight.  190 µls of M9 broth with and without the free or nanoencapsulated 
baicalein or quercetin (various concentrations) were then inoculated with 10µls of bacterial 
cultures and incubated at 37ࡈ C for 48 h without shaking. Unloaded kanamycin (1mM) was also 
added as a positive control and M9 broth as negative control. The polystyrene tissue culture 
microplate was sealed with a para film to prevent medium evaporation prior to incubation.  
After incubation, plates were carefully rinsed 2-3 times with double-distilled water to remove 
loosely attached cells. The microplate was air dried for one hour  before adding 200 µl per well 
of 0.4% crystal violet solution  to the adhered cells in the wells and it was left at room 
temperature for 15min.  Excess stain was then removed by rinsing the wells with 200 µl per 
well of distilled water three times. The microtiter plate was then air-dried again for 1 h after 
which 200 µl per well of absolute ethanol was added to solubilize the dye. Intensity was 
measured at OD590nm by using a Safire Tecan-F129013 Microplate Reader (Tecan, Crailsheim, 
Germany). For each experiment background staining was corrected by subtracting the crystal 
violet bound to un-inoculated controls from those of the samples. The experiments were done 
in triplicates and average values were calculated. To estimate the antibiofilm activity (%) of a 
given treatment the following equation was used. 
Antibiofilm activity (%) = [1- (ODTest sample-ODBlank)/ (ODUntreated control - ODBlank)] x100 
  
2.9: Cell viability assay 
2.9.1: Cell culture 
Mandin Darby Canine Kidney (MDCK) cells clone 7 (C7) were cultured in 75 cm² flasks using 
MEM supplemented with 10% fetal bovine serum, 1% L-glutamine (200 mM) and 1% 
penicillin-streptomycin (10000 units penicillin, 10000 units streptomycin in 0.9% NaCl). The 
cell cultures were maintained in a humid atmosphere at 37 °C with 5% CO2 (Sanyo MCO-
19AIC, Panasonic Biomedical Sales Europe BV, AZ Etten Leur, Netherlands). Cells from 
passages 17 - 25 were used for all experiments, which were carried out as independent 
triplicates on different days. After reaching microscopic confluence, the cells were washed with 
10 ml phosphate buffered saline (PBS) and trypsinized with 10 ml 0.05% trypsin in EDTA (1x) 
buffer. After detachment, 10 ml of MEM was added to the trypsin buffer. The cell suspension 
was centrifuged at 1000 r.p.m for 5 min (Rotina 420 R, Hettich GmbH, and Tuttlingen, 
Germany). The excess of medium was removed by sucking and the cell pellet was resuspended 
in 1 ml MEM. A 10-ȝODOLTXRWRIWKHFHOOVXVSHQVLRQZDVGLOXWHGZLWKȝOWU\SDQEOXHDQG
the number of cells was counted with an improved Neubauer chamber before seeding. The cells 
were subcultured by splitting at a ratio of 1:10. 
 
2.9.2: Mammalian cell (MDCK-C7) line cytotoxicity tests: 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) assay  
The cytotoxicity of both free and nanocapsulated baicalein and quercetin were evaluated using 
an MTT assay protocol as used before [46- 48]. %ULHIO\  ȝO RI FHOO VXVSHQVLRQ ZDV
transferred to each well of a 96-well polystyrene tissue culture plate (~104 cells per well) and 
was incubated at 37 °C with 5% CO2 (Sanyo MCO-19AIC, Panasonic Biomedical Sales Europe 
BV, AZ Etten Leur, Netherlands) for 24h to allow attachment of the cells. Then the attached 
cells were washed twice with supplement-free MEM before the various concentrations of either 
free or nanoencapsulated sample were added unto the wells and the cells were incubated for 
KDWVDPHFRQGLWLRQVDVDERYH7KHVDPSOHVZHUHWKHQUHPRYHGDQGUHSODFHGZLWKȝO
supplement-IUHH 0(0 DQG  ȝO RI 077 UHDJHQW  PJPO RI WKLD]RO\O EOXH WHWUD]ROLXP
bromide) per well. After 4 h incubation at 37 °C with 5% CO2, the medium and MTT reagent 
were removed and the dye was dissolved in DMSO (100µls per well). After orbital shaking at 
USPIRUPLQWKHDEVRUEDQFHZDVPHDVXUHGDWȜ QPLQDSafire Tecan-F129013 
Microplate Reader (Tecan, Crailsheim, Germany). We used 4% Triton X-100 in PBS as a 
positive control. The following formula was used to calculate the percentage relative viability 
of the treatments against the MDCK-C7 cell line. 
 
    
3. Results 
3.1: Physicochemical properties of baicalein and quercetin nanocapsules 
The MDP chitosan (Mw- ~115kDa and DA- ~42%) was used in nanocapsules formation.  Table 
1 presents the various physicochemical parameters and encapsulation efficiency of both 
baicalein and quercetin.  The Z-average diameter of each formulation ranged within a narrow 
Pa% Cell Survival = Mean absorbance in test wells          X 100
Mean absorbance in control wells
  
range from ~185 to ~194 nm, with a low polydispersity index (PDI) fluctuating from ~ 0.12 to 
~ 0.15. The nanocapsules were highly positively charged with ]potential values ranging 
between ~ + 47.6 and + 48.4 mV and a very high capacity of association with baicalein (87%) 
and quercetin (99%). For the resuspended quercetin NCs pellet, association efficiency of 99.9% 
was deduced. 
 
3.2:  Stability test for baicalein and quercetin nanocapsules 
The colloidal stability of the both flavonoids-loaded and of unloaded (blank) nanocapsules was 
determined and figure 1 shows in both mediums (M9 and MEM) that the average size and PDI 
remained constant for all the systems, in agreement with previous studies on chitosan 
nanocapsules [49, 50]. 
3.3: Release assays of baicalein and quercetin nanocapsules 
The release of both flavonoids-loaded nanocapsule formulations was examined in M9 bacterial 
growth medium as illustrated in Figure S4 (Supplementary Information) and the calibration 
curves (Supplementary Information S3). Both flavonoids-loaded NCs had a slow but steady 
release of the quercetin up to 5 h after which the release rate increased tremendously. But 
generally, baicalein-loaded nanocapsules had a more pronounced release as compared to 
quercetin. 
 
3.4: Antiquorum sensing activity of chitosan nanoencapsulated and free baicalein and 
quercetin 
We investigated the influence of applying different concentrations of both free and chitosan-
nanoencapsulated baicalein and quercetin on the relative growth and the relative quorum 
sensing of the transformed E. coli Top 10 biosensor strain that expresses GFP production only 
under the influence external 3OC6HSL [51-53]. A close inspection of Figure 2 reveals that free 
baicalein (Figure 2i-a) did not have any substantive inhibitory effects on the QS response of 
the bacteria. At high doses (> 2.53 x 10-3 mM) it seemed to be toxic as the bacteria OD was 
reduced. However, upon encapsulating baicalein and applied at similar doses as for the free 
form, the toxicity at high doses was abrogated. Baicalein encapsulation also seemed to enhance 
QS response especially at 2.53 x 10-4 mM and 6.25 x 10-5 mM concentrations. 
Figure 3 (i) illustrates individual plots for fluorescence (a), OD600 (b), and FL/OD600 (c) for 
representative treatments of baicalein-loaded nanocapsules at the two selected flavonoid 
concentrations where inhibition of QS was observed (Figure 2i-b), namely 2.53 x 10-4 and 6.25 
x 10-5 mM. Notice that the data confirm that there was a selective inhibition of the expression 
of fluorescence and that this effect was not at the expense of a reduction in cell viability, apart 
from a very slight reduction in OD600 at 2.53 x 10-4 mM.  Comparable results as those obtained 
for baicalein were observed upon treatment of the E. coli Top 10 biosensor with free quercetin 
(Figure 2 LL,W¶VFOHDUWKDWat doses greater than 6.25 x 10-3 mM, quercetin exerted significant 
toxicity (p<0.05) in a dose dependent manner (Figure 2 ii-a). Also, at concentrations < 3.25 x 
10-3 mM there seems to occur a consistent reduction in the relative QS response, though this 
effect does not reach statistical significance.  
 
  
With quercetin-loaded nanocapsules treatments this scenario changed (Figure 2 ii-b). They 
exhibited a protective effect on the toxicity of quercetin on E. coli Top 10 bacteria even at the 
highest applied doses (8.4 x 10-3 mM).  About the QS inhibition activity, notice that there was 
D ³*ROGLORFNV´-type of effect, and the minimum values were attained at intermediate 
concentrations ~3.91 x 10-4 mM with less pronounced effects either at greater or lower 
concentrations. Figure 3 (ii) depicts individual plots for fluorescence (a), OD600 (b), and 
FL/OD600 (c) for representative treatments of quercetin-loaded nanocapsules at three flavonoid 
concentrations around that where the maximum inhibition of QS was observed (Figure 2 ii-b). 
Notice that in this case, the results confirm that there was a selective inhibition of the expression 
of fluorescence and that this effect was not at the expense of a reduction in cell viability, apart 
from a very slight reduction in OD600 at 2.53 x 10-4 mM.  It is evident that the unloaded 
nanocapsules had no effect neither on the fluorescence nor on OD600 of E. coli Top 10 
biosensor. The null effect of unloaded nanocapsules on both the growth and the QS response 
was confirmed at various concentrations in the range 6.25 x 10-6 to 8.80 x 10-3 mM (See 
supplementary data-S5).      
3.5: E. coli Top 10 biosensor antibiofilm formation 
We examined the effect of free solution and flavonoid-loaded nanocapsules on the biofilm 
formation activity of the E. coli Top 10 QS biosensor strain (Figure 4). Notice that for both 
type of systems, biofilm formation was inhibited mostly at low concentrations upon treatment 
with both nanoencapsulated phytochemicals. Indeed, below 6.25 x 10-4 and 3.91 x 10-4 mM 
concentrations of baicalein- and quercetin-loaded nanocapsules, respectively, no significant 
differences were observed with respect to the positive control (kanamycin-1mM). By contrast, 
free solutions of both flavonoids showed invariably significantly lower inhibition of biofilm 
formation than kanamycin and the encapsulated phytochemicals at low concentrations. 
Supplementary data-S6 shows the image of representative appearance of microtiter plates 
during the biofilm formation assay by E. coli Top 10 biosensor upon treatment with varying 
concentrations of: (a) Baicalein- and (b) Quercetin-loaded nanocapsules after treatment with 
0.4% CV and before dissolving the stain with absolute ethanol. Unloaded NCs seemed to also 
have a slight effect on biofilm formation inhibition especially at low dosages (supplementary 
data-S7).   
3.6: Mammalian cell cytotoxicity tests ± MDCK-C7 cell line 
The influence of various concentrations of both free and nanoencapsulated baicalein and 
quercetin on the metabolic competence (mitochondrial activity) of MDCK-C7 cell line was 
assessed using MTT assay. The results (Figure 5) show that with free baicalein and quercetin 
in most of the concentrations the relative viability was below 50%, a scenario that improved 
with introduction of nanoencapsulated baicalein and quercetin. It is also quite clear that at 
higher concentration especially with quercetin there is more relative viability. This may be a 
false positive result as the MTT reagents used have been found to be influenced by certain 
doses of quercetin. But generally in both phytochemicals it can be concluded that 
nanoencapsulation improved their relative viability with the MDCK cell line. 
  
4. Discussion 
A combination of both physicochemical and biological analysis was used to investigate the 
effects of free and chitosan-based nanocapsules loaded with baicalein and quercetin against a 
bioengineered E.coli Top 10 biosensor and MDCK-C7 mammalian cells. The chitosan (DA 
42%) used in this study, does not have antibacterial activity and, therefore, it is best suited for 
producing nanocapsules for bacterial quorum sensing studies [52]. The physicochemical 
characteristics of the nanoformulations in terms of size, zeta potential, encapsulation efficiency 
(Table 1) and stability in biological media (Figure 1) concurred closely with those of previous 
reports [25, 54]. The presence of the flavonoids did not have a dramatic effect on the Z-average 
size. Both flavonoids associated with very high efficiencies, namely quercetin (99%) and 
baicalein (87 %), in agreement with findings of other groups [50]. Their zeta potential was 
strongly positive, diagnostic that chitosan adsorbed at the outer shell and of the exposure its 
protonated amine groups. The colloidal stability of the nanocapsules in biological media (M9 
and MEM), as assessed from the evolution of the particle size revealed that all the systems 
were stable as documented in previous studies [49, 50]. 
The in vitro release kinetics data of the payloads from both flavonoid-loaded NCs revealed a 
somewhat distinct pattern for each. Baicalein released only ~20 % (Figure S4, Supplementary 
Information) over the first 5 h, while quercetin released ~10% (Figure S4, Supplementary 
Information) over the first 4 h and thereafter the release suddenly increased up to ~40 % in 
both nanocapsules.  The sui generis release pattern observed in both cases, particularly at long 
times, could not be attributed to disintegration of the nanocapsules, as no change in the size 
was noticed during the evaluation of the colloidal stability (Figure 1). Alternatively, erosion of 
the nanocapsule shell could explain this anomalous sudden increase in the release of both 
payloads at times exceeding ~4 h of incubation. The overall lower release of quercetin, as 
compared to baicalein, could be associated to slight differences in solubility (i.e., log P) that 
could result in differences in the partitioning of the compound between the oil-core of the 
droplet and the continuous aqueous phase. QS bioassays did indicate that free baicalein did not 
have much impact at most of the tested concentrations. In fact, at higher concentration it was 
observed that both free flavonoids seem to be toxic towards the E. coli Top 10 biosensor. Both 
phytochemicals had been reported to inhibit quorum sensing-dependent processes in a P. 
aeruginosa PA01 strain, but this is only achieved at higher concentrations too [19, 37]. 
However, in their encapsulated forms, our results demonstrate that their QS inhibition ability 
improves when tested in our E. coli Top 10 biosensor.  PA01 strain has a specialized QS 
circuitry that includes LasR, Rh1R and QscR than the LuxR circuit of the transformed E. coli 
Top 10 strain used in this study. Each of these circuits use different type of autoinducers and 
therefore, it is likely that these two flavonoids do not compete for the binding site of the 
involved receptors with the cognate autoinducers, but they may act by different mechanisms. 
One possibility is that they inhibit specific enzymes like autoinducer synthases, this cannot be 
ruled out from our studies, as E. coli Top 10 QS biosensor strain does not synthesize the AHL 
AI. Also, it could be that both flavonoids bind at the LuxR receptor not at the binding site, but 
at a different domain that would affect the binding of the dimerized LuxR to the DNA promoter.  
Yet an alternative explanation is that flavonoids accumulate rapidly at the lipidic membrane of 
bacteria [55], and hence, block the diffusion of AHL to the cytosol. This last effect may explain 
why the free flavonoids exert a toxic response in a dose-dependent manner at high 
  
concentrations, while when loaded into nanocapsules, it is likely that the flavonoids are 
released under a slow kinetics, and hence, bacteria can keep up with the pace to metabolise 
them. About the QS response, the available evidence shows that free baicalein does not have 
any significant effect on FL/OD600 when dosed at sub-lethal concentrations. In the encapsulated 
form, it seems that at intermediate concentrations (2.53 x 10-4 and 6.25 x 10-5 mM), there is an 
effect, although this does not seem to be consistent, as it was not evident at 1.24 x 10-4 mM. 
Even when we could not draw too many conclusions on baicalein-loaded nanocapsules in this 
regards, we observed a comparable, though much more defined trend in quercetin-loaded 
nanocapsules under the same experimental setup.  
In the case of the effect of free quercetin, the toxic response was very much like that of 
baicalein, and a dose-dependent response was appreciated at concentrations below 6.25 x 10-3 
mM and it also exerted no effect on the relative QS response at any of the tested doses. On the 
other, the quercetin-loaded nanocapsules exhibited no toxicity, in line with baicalein-loaded 
ones. What draws attention most in these systems though, was the effect of the concentration 
on the relative QS response and the clear so-FDOOHG³*ROGLORFNV´HIIHFWZKLFKVKRZVDFOHDU
maximum inhibition at an intermediate concentration of   3.91 x 10-4 mM.  An interpretation 
to this effect can be offered in line with previous studies carried out in our laboratory showing 
that unloaded chitosan-based nanocapsules obtained from the same chitosan sample as in the 
present study and under an identical preparation protocol, at specific number ratios of 
nanocapsules/bacterium inhibit the relative QS response in a very similar way as we report 
here. This has been attributed to the aggregation exerted by the capsules on the E. coli bacteria, 
the result of electrostatic interactions [52]. Since in our experiments the dose of flavonoids was 
controlled not by the actual concentration loaded in the capsules, but by the total amount of 
added formulations, our results therefore, concur with the mentioned previous findings. Also, 
along with the aggregation effect, the possibility that the nanocapsules are able to deliver their 
payloads locally at the cell wall cannot be ruled out.  
In turn, results of the quantitative biofilm inhibition studies clearly revealed that both 
flavonoids do have an incipient ability to inhibit biofilm formation of E. coli Top 10 when 
dosed in free form. However, this capacity was much clearly enhanced upon their 
nanoencapsulation when the doses were lower than ~2.0-2.5 x 10-4 mM, and in both cases, 
almost similar results were observed between the two types of systems. A possible explanation 
to the loss in activity observed at greater doses could be associated to the aggregation effects 
discussed above. It is likely that aggregation may favour biofilm formation, even when the QS 
response seems to be inhibited (cf. Figure 2 ii-b) [7, 56].  
Overall, our findings concur with previous studies that have documented that these 
phytochemicals can inhibit biofilm formation [19, 37]. For instance, baicalein has been 
reported to inhibit P. aeruginosa PA01 biofilm formation at concentrations of 32-128 µg/mL 
[37], while quercetin at concentrations of 16 µg/mL produced the highest inhibitory antibiofilm 
formation effect against PA01 among the concentrations used - 8, 16, 32 and 64 µg/mL [19].  
It is therefore, a clear indication that the inhibition of biofilm formation could be dependent on 
the pathogen of interest and that the observed effects are not necessarily dose-dependent as in 
both studies lower concentrations had better results than higher ones. Alternatively, since it is 
most likely that these two phytochemicals could not be competitors with autoinducers at the 
receptor level as they have shown inhibitory effects to bacteria of different QS circuits, it could 
  
be argued that their biofilm inhibiting activity stems on other mechanisms. One such pathway 
could be inhibition of diguanylate cyclases (DCGs) that is responsible for the production bis-
¶-¶-cyclic dimeric guanosine monophosphate (c-di-GMP) in bacteria cell; a molecule that 
controls the biosynthesis of adhesins and exopolysaccharides associated with biofilm formation 
[57].  A few phytochemicals have been reported to have such an activity. For instance, N-[4-
(phenylamino)phenyl]-benzamide was reported to possesses a broad-spectrum activity, 
reducing biofilm formation of both V. cholerae and P. aeruginosa by inhibiting the DGCs and 
it did not possess any effect on the bacterial growth [58, 59]. Yet another possible target could 
be the phytochemicals compounds able to enhance dispersal of biofilms mainly by targeting 
the breakdown of the extracellular polysaccharide that makes up the extracellular matrix.  Some 
compounds like norspermidine have been reported to have an enhanced dispersal of 
multispecies waste water biofilms when it was combined with silver nitrate [60, 61]. To 
account for the enhanced inhibition observed when the flavonoids were loaded in the 
nanocapsules, we can argue that there is a local delivery effect, that it is enhanced at low 
concentrations. In our previous study, we showed that 100% of the chitosan nanocapsules bind 
to E. coli Top 10, when they are dosed at low concentrations, below the optimal 
³VWRLFKLRPHWULF´QDQRFDSVXOHEDFWHULXPELQGLQJSRLQW [52]. It is also conceivable, that under 
such scenario, the nanocapsules release their payloads in a sustained and controlled manner. 
Cell viability studies were conducted using the MTT assay and they revealed that both baicalein 
and quercetin are cytotoxic to MDCK- C7 cells when dosed in solution, and produced a 
reduction on relative viability to less than ~50%. However, upon their nanoencapsulation, there 
was a notorious increase in cell viability. An explanation can be that the confinement of the 
phytochemicals as previously argued, could result in a controlled releases of the payloads, and 
hence, in lower doses over the time span of the experiment. In studies conducted in our 
laboratory on capsaicin-loaded nanocapsules [25], similar cytoprotective effects as those 
reported here were observed. In the same studies, it has been shown that the nanocapsules are 
up taken avidly by MDCK-C7 cells. If the NCs are up taken in intact form, hence, the loaded 
flavonoids are likely to bypass the cell membrane, and hence, be delivered intracellularly 
(possible antioxidant effect in mitochondria). Ongoing studies in our laboratory are addressing 
whether the nanocapsules are taken up in intact, partially or fully degraded form. 
5. Conclusion 
In this study, we have gained proof-of-concept that baicalein and quercetin-loaded 
nanocapsules modify favourably the bioactivity of both flavonoids, namely, they prevent E. 
coli 7RS  46 EDFWHULD WR ³OLVWHQLQJ´ WKH VLJQDOOLQJ RI $+/ DGGHG H[RJHQRXVO\ 7KHVH
effects were much clearly observed for quercetin-loaded nanocapsules and were maximized at 
an intermediate concentration below and above which the magnitude of the response decreases. 
7KLV³*ROGLORFNV´UHVSRQVHZHDWWULEXWHLWWRWKHSRVVLEOHUROHRIEDFWHULDDJJUHJDWLRQH[HUWHG
by the capsules. The consequences of encapsulating the flavonoids were even more accentuated 
on the capacity to inhibit biofilm formation in the same bacterial strain, and only at 
concentrations below that at which the maximum QS inhibition was observed. Whether the 
inhibition of QS resulted also in antibiofilm formation, under conditions that 100% of the 
capsules bound to bacteria, is yet to be confirmed. Yet another favourable effect of the 
  
nanoencapsulation of the flavonoids was the cytoprotective effect observed in MDCK-C7 cells. 
The potential use of these systems in food and health is yet to be fully realized. 
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Figures Captions 
 
Figure1: Evolution of the Z-average diameter size with time of flavonoid-loaded and unloaded 
(blank) nanocapsules and incubated at 37 °C in: (a) M9 and (b) MEM media (n=3). 
 
 
Figure 2: Flavonoid in vitro release profiles during incubation in M9 medium at 37 °C of: (a) 
Baicalein -loaded nanocapsules, and (b) Quercetin -loaded nanocapsules. 
 
Figure 3: Effect of varying doses of baicalein (i) and quercetin (ii) as (a) free solution, and (b) 
loaded nanocapsules on the relative growth (OD600) and relative quorum sensing activity 
(FL/OD600), evaluated in a E. coli Top 10 quorum sensing biosensor strain. Average values 
represent average ± S.D. (n=3). 
 
Figure 4: Evolution during the culture of E. coli Top 10 quorum sensing biosensor strain (in 
M9 medium at 37 °C). Panels: (a) fluorescence expression, (b) growth (OD600), and (c) quorum 
sensing (Fl/OD600) upon treatment with (i) baicalein and (ii) quercetin-loaded nanocapsules at 
different doses (as indicated in legend). 
 
Figure 5: Effect of varying doses of: (a) baicalein and (b) quercetin after treatment in free 
solution and in both flavonoids-loaded nanocapsules (as shown in legends), on the relative 
inhibition of biofilm formation of  E. coli Top 10 biosensor strain (cultured in M9 liquid 
medium at 37 °C). Kanamycin (conc. 1mM) was used as positive control. Average values 
represent average ± S.D. (n=3). 
Figure 6: Effect of varying doses of: (a) baicalein and (b) quercetin after treatment in free 
solution and in both flavonoids-loaded nanocapsules (as shown in legends), on the cell viability 
of MDCK-C7 cells (cultured in supplemented MEM at 37 °C). Average values represent 
average ± S.D. (n=3). 
 
 
  
 
 
 
 
 
 
 
Table 1: Characteristics of chitosan-coated nanocapsules (mean averages ± SD, n=3) 
 
a
 Polydispersity index 
b
 Flavonoid A.E. (%) = [(Conc. flavonoidtotal ± Conc. flavonoidunloaded)/(Conc. flavonoidtotal)] x 100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nanocapsules 
Formulation 
Z-av.  
diameter 
(nm) PDIa 
]potential 
(mV) 
Flavonoid 
association 
efficiency(A.E., %)b 
Quercetin-loaded 194 ± 4 0.12  +48.4 ± 3.46 99 ± 1.2 
Baicalein-loaded 187 ± 2 0.12  +48.1 ± 2.03 87 ± 5.1 
Unloaded  185 ± 2 0.15  +47.6 ± 2.38 ------ 
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Figure  S1: Chemical structures of baicalein and quercetin 
 
 
 
Figure S1 (a): Quercetin hydrate 
MW- 302.24 
 C15H10O7 ·  xH2O 
Log P, 2.16 
Figure S1 (b):  Baicalein 
MW- 270.24 
C15H10O5 
Log P, 3.311 
 
  
 
 
 
 
 
Figure S2: Calibration curves for baicalein (a) and quercetin (b) diluted in absolute ethanol 
 
 
Figure S3: Calibration curves for baicalein (a) and quercetin (b) diluted in M9 medium. 
 
 
 
 
 
Figure S4: Flavonoid in vitro release profiles during incubation in M9 medium at 37 °C of: 
(a) Baicalein-loaded nanocapsules, and (b) Quercetin-loaded nanocapsules  
  
 
 
 
 
 
 
Figure S5: Effect of blank NCs on the quorum sensing of E. coli Top 10 biosensor. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure S6: Appearance of microtiter plates during the biofilm formation assay by E. coli Top 
10 biosensor upon treatment with varying concentrations (shown on legends on both plates) 
of:  (a) Baicalein-loaded nanocapsules, and (b) Quercetin-loaded nanocapsules. Biofilms are 
stained with 0.4% crystal violet. Negative and positive controls were M9 medium and 
kanamycin (1mM) respectively. 
 
  
 
Figure S7: Effect of unloaded chitosan nanoparticles on biofilm formation of E. coli Top 10 
biosensor. 
 
